Mankind Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MANKIND PHARMA, and what generic and branded alternatives to MANKIND PHARMA drugs are available?
MANKIND PHARMA has forty-two approved drugs.
There are two tentative approvals on MANKIND PHARMA drugs.
Drugs and US Patents for Mankind Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mankind Pharma | APREMILAST | apremilast | TABLET;ORAL | 211734-003 | Feb 7, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mankind Pharma | NITROFURANTOIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 217272-002 | Mar 21, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mankind Pharma | HALOPERIDOL | haloperidol | TABLET;ORAL | 216918-002 | Apr 11, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mankind Pharma | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 217271-002 | Nov 1, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mankind Pharma | AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride | TABLET;ORAL | 213999-003 | Feb 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mankind Pharma | NITROFURANTOIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 217272-003 | Mar 21, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mankind Pharma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 078771-002 | Sep 28, 2009 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.